Show
Sort by
-
Biomarkers in gynecological cancer : the potential of tumor infiltrating immune cells and circulating extracellular vesicles
(2022) -
- Journal Article
- A1
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study
-
- Journal Article
- A1
- open access
Association of cell death markers with tumor immune cell infiltrates after chemo-radiation in cervical cancer
-
- Conference Paper
- C3
- open access
Automated liquid handling for highly specific and reproducible density‐based separation of extracellular vesicles from human body fluids
-
Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma
-
Recombinant extracellular vesicles as biological reference material for method development, data normalization and assessment of (pre-)analytical variables
-
Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer
-
- Journal Article
- A1
- open access
Unravelling the proteomic landscape of extracellular vesicles in prostate cancer by density-based fractionation of urine
-
Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead towards personalized treatment
-
- Journal Article
- A1
- open access
Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction